Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
27.7%  /
70.8%
4.2x
7.4x
0.2x
6.9%
-15.7%
..
0.0%
-850.0% 
28.6%  /
68.2%
>200x
>200x
1.4x
-273.3%
-63.3%
..
0.0%
-316.7% 
0.0%  /
50.0%
>200x
>200x
102.4x
-1366.7%
-1100.0%
..
0.0%
-10.0% 
8.0%  /
32.8%
>200x
>200x
1.2x
-35.4%
3.3%
..
0.0%
5.2% 
20.0%  /
31.1%
70.4x
93.5x
13.7x
18.3%
22.0%
2026-03-28
0.0%
1.6% 
73.4%  /
20.9%
>200x
15.4x
2.3x
-5.7%
-78.6%
..
0.0%
-112.1% 
1.1%  /
18.0%
>200x
>200x
12.1x
3.9%
7.2%
2026-02-07
0.0%
0.6% 
11.1%  /
16.3%
8.7x
9.3x
0.6x
6.8%
0.0%
2025-11-25
0.0%
--- 
-23.1%  /
15.7%
3.6x
6.9x
0.4x
10.7%
5.3%
..
0.0%
7.6% 
2.4%  /
14.5%
48.3x
48.3x
1.7x
3.5%
1.2%
..
0.0%
0.7% 
0.0%  /
13.3%
78.3x
69.5x
0.7x
1.0%
-6.1%
..
0.0%
-9.5% 
23.6%  /
10.6%
15.9x
9.7x
2.1x
13.1%
7.7%
..
0.0%
3.1% 
21.6%  /
9.7%
>200x
>200x
0.1x
-4.0%
-15.6%
..
0.0%
-5 800.0% 
0.0%  /
9.6%
>200x
>200x
1.7x
-0.8%
-0.8%
..
0.0%
-0.6% 
-11.8%  /
9.0%
>200x
>200x
1.2x
-5.0%
-2.5%
2026-02-07
0.0%
-1.9% 
-72.7%  /
8.9%
>200x
>200x
120.8x
-14.5%
75.8%
2025-12-01
0.0%
0.6% 
26.7%  /
8.7%
>200x
>200x
0.5x
-11.4%
-12.9%
..
0.0%
-20.9% 
7.8%  /
8.7%
22.4x
26.2x
6.4x
28.4%
-33.1%
2026-02-15
1.2%
-5.9% 
0.0%  /
6.8%
1.5x
6x
0.1x
-5.6%
0.0%
2026-02-05
0.0%
--- 
29.0%  /
6.4%
65.1x
50.5x
15x
23.1%
0.0%
..
0.5%
--- 
2.0%  /
4.3%
>200x
24x
1.8x
-3.4%
-1.1%
2025-11-25
0.0%
-0.5% 
8.6%  /
4.1%
20.4x
20.8x
3.6x
18.3%
-21.6%
2026-02-07
0.0%
-6.5% 
15.2%  /
3.9%
46.8x
39.2x
1.9x
4.1%
4.7%
2026-02-05
0.0%
2.6% 
7.5%  /
3.8%
21.4x
19.5x
5.8x
27.3%
8.3%
2026-02-13
2.1%
1.5% 
-5.2%  /
3.6%
13.7x
9.4x
3.1x
21.8%
-1.7%
..
0.0%
-0.6% 
7.5%  /
3.2%
10.5x
9.8x
2.7x
25.5%
1.8%
2025-11-18
5.2%
0.7% 
-27.6%  /
2.5%
11.7x
38.9x
1.7x
14.0%
11.0%
2026-02-11
0.0%
6.7% 
13.2%  /
2.5%
50.3x
16.5x
10.1x
21.7%
-54.0%
..
0.0%
-5.6% 
-62.5%  /
1.8%
>200x
>200x
4.1x
-71.4%
-7.1%
..
0.0%
-1.7% 
-13.5%  /
1.8%
7.7x
8.1x
1.3x
16.5%
4.8%
..
2.5%
5.0% 
-1.6%  /
1.6%
9.6x
4.2x
3.5x
35.6%
-23.7%
..
0.0%
-7.7% 
-3.2%  /
0.7%
11.4x
15.7x
1.1x
9.8%
6.6%
..
4.3%
5.5% 
-8.6%  /
0.4%
>200x
72.8x
1.5x
-2.7%
0.0%
..
0.0%
--- 
0.0%  /
0.0%
>200x
>200x
2.4x
-23766.7%
137.5%
2025-11-14
0.0%
37.9% 
-4.7%  /
-0.3%
8.9x
9x
1.3x
14.2%
-20.5%
..
3.2%
-13.7% 
-23.6%  /
-0.4%
>200x
>200x
2.5x
-13.9%
8.9%
..
0.0%
3.7% 
11.4%  /
-0.7%
25.8x
27.7x
2.9x
11.3%
-0.2%
..
2.2%
-0.1% 
6.2%  /
-1.6%
15x
22.7x
2.7x
17.7%
-0.1%
2026-02-05
0.0%
0.0% 
-0.9%  /
-1.7%
10.7x
8.4x
1.5x
12.9%
-3.7%
..
2.6%
-2.4% 
-7.5%  /
-12.2%
>200x
>200x
0.6x
-21.3%
-26.9%
..
0.0%
-2 233.3% 
-3.4%  /
-12.5%
6.1x
7.7x
0.4x
10.3%
17.8%
2026-03-07
0.0%
16.8% 
50.6%  /
-13.5%
10.3x
121.2x
2.1x
20.7%
39.1%
2026-02-27
0.0%
60.0% 
-3.7%  /
-16.2%
15.6x
22.4x
0.5x
3.0%
21.7%
..
0.0%
20.7% 
-14.8%  /
-16.3%
136.5x
191.9x
8.4x
6.0%
48.3%
2026-02-21
0.0%
5.9% 
2.3%  /
-16.8%
>200x
16.2x
0.6x
-43.6%
-32.0%
2025-11-19
0.0%
-74.3% 
0.0%  /
-27.3%
>200x
7x
12.1x
-110.0%
-60.0%
2025-11-14
0.0%
-5.0% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2025-11-19
#reports #VREX

[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194325)
(2025-11-18, After Market Close):

- Revenue +11.2% YoY (vs -2.9% in previous quarter and historical rate -0.3%)
- EBITDA +40.9% YoY (vs -473.7% in previous quarter and historical rate -16.1%)
- EBITDA margin 13.5% increased compared to 10.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 104.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.9x

The company showed EPS +$0.29 per share
2025-11-19
#reports #ESLT

[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for 2025 q3
(2025-11-18, Before Market Open):

- Revenue +11.9% YoY (vs +21.3% in previous quarter and historical rate +12.2%)
- EBITDA +30.3% YoY (vs +29.7% in previous quarter and historical rate +17.8%)
- EBITDA margin 11.2% increased compared to 9.6% same period last year
- Net Debt decreased by $200 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 29.5x compared to historical level (75th percentile) of 26.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +3.9% vs S&P500 -0.4%
2025-11-19
#reports #BRBR

[BellRing Brands](https://eninvs.com/all.php?name=BRBR) (Packaged Foods) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BRBR&q=2025 q3&id=902611)
(2025-11-18, Before Market Open):

- Revenue +16.5% YoY (vs +6.4% in previous quarter and historical rate +19.3%)
- EBITDA -9% YoY (vs -56.8% in previous quarter and historical rate +30.0%)
- EBITDA margin 15.6% decreased compared to 20.0% same period last year
- Net Debt increased by $48 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 28.6x
- EV/Sales multiple is 2x

The company showed EPS +$0.48 per share. At the opening of the session the share price went down -4.8% vs S&P500 -0.4%
2025-11-18
#reports #ZYXI

[Zynex](https://eninvs.com/all.php?name=ZYXI) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194320)
(2025-11-17, After Market Close):

- Revenue -74% YoY (vs -56.0% in previous quarter and historical rate -4.8%)
- EBITDA -960% YoY (vs -400.0% in previous quarter and historical rate -66.8%)
- EBITDA margin -330.8% decreased compared to 10.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (17.5% of market cap)
- FCF (LTM) -$0 bln (negative), 122.8% of market cap
- EV/Sales multiple is 0.7x

The company showed EPS -$1.42 per share
2025-11-18
#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q3
(2025-11-17, After Market Close):

- Revenue -54.5% YoY (vs 0.0% in previous quarter and historical rate -4.9%)
- EBITDA margin -353.3% decreased compared to -193.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 16.8% of market cap
- EV/Sales multiple is 2.2x

2025-11-18
#reports #BRC

[Brady Corporation](https://eninvs.com/all.php?name=BRC) ( Identification products manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194318)
(2025-11-17, Before Market Open):

- Revenue +7.4% YoY (vs +15.7% in previous quarter and historical rate +16.6%)
- EBITDA +14.5% YoY (vs -5.4% in previous quarter and historical rate +17.1%)
- EBITDA margin 19.5% increased compared to 18.3% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 11.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 2.2x

The company showed EPS +$1.11 per share. At the opening of the session the share price went up +2.8% vs S&P500 -0.3%
2025-11-18
#reports #ARMK

[Aramark](https://eninvs.com/all.php?name=ARMK) (Catering, Facility and Human Resources Service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ARMK&q=2025 q3&id=902456)
(2025-11-17, Before Market Open):

- Revenue +14.3% YoY (vs +109.8% in previous quarter and historical rate +10.5%)
- EBITDA +75% YoY (vs +136.7% in previous quarter and historical rate +17.1%)
- EBITDA margin 11.5% increased compared to 7.5% same period last year
- Net Debt decreased by $1 bln since the start of the year (10.8% of market cap)
- FCF (LTM) -$1.2 bln (negative), 12.6% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 0.6x

The company showed EPS +$0.33 per share. At the opening of the session the share price went down -5.8% vs S&P500 -0.3%
2025-11-18
#reports #SOHU
@ china

[Sohu.com](https://eninvs.com/all.php?name=SOHU) (Online advertising service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SOHU&q=2025 q3&id=902467)
(2025-11-17, Before Market Open):

- Revenue +18.4% YoY (vs -26.7% in previous quarter and historical rate -8.3%)
- EBITDA +3.3% YoY (vs -2300.0% in previous quarter and historical rate -48.0%)
- EBITDA margin 469.4% decreased compared to 538.2% same period last year
- Net Debt decreased by $48 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 20.6% of market cap
- EV/Sales multiple is -0.6x

At the opening of the session the share price went up +4.7% vs S&P500 -0.3%
2025-11-17
#dividend #NSA

National Storage Affiliates Trust will pay dividends in the amount of 0.57 USD per share on 2025-12-12, which is 1.9% of the current price 29.4. Together with previous payments, the annual dividend yield will be 7.8%

(2025-09-12: 0.57 USD)
(2025-06-12: 0.57 USD)
(2025-03-13: 0.57 USD)
2025-11-16
(review)
Weekly results
for USD strategies

US Leaders: +3.1%

Global Commodities: +2.4%

Trending Ideas: -0.6%

Rising Stars: -2.2%

vs S&P500: +0.1%
2025-11-15
#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194251)
(2025-11-13, After Market Close):

- Revenue +32% YoY (vs +2.8% in previous quarter and historical rate +103.8%)
- EBITDA margin -774.0% increased compared to -1175.6% same period last year
- Net Debt increased by $2 bln since the start of the year (6279.1% of market cap)
- FCF (LTM) -$8.9 bln (negative), 27728.9% of market cap
- EV/Sales multiple is 6.9x

At the opening of the session the share price went up +3.3% vs S&P500 -1.1%
2025-11-15
#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194247)
(2025-11-06, After Market Close):

- Revenue +31.4% YoY (vs +85.1% in previous quarter and historical rate +54.0%)
- EBITDA margin -489.4% increased compared to -908.5% same period last year
- Net Debt decreased by $776 mln over the past reporting period (7318.9% of market cap)
- FCF (LTM) -$5 bln (negative), 47233.2% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -0.2% vs S&P500 -0.4%
2025-11-15
#reports #OMI

[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194224)
(2025-10-30, Before Market Open):

- Revenue -74.4% YoY (vs -74.5% in previous quarter and historical rate -9.6%)
- EBITDA +5.8% YoY (vs -76.2% in previous quarter and historical rate -20.5%)
- EBITDA margin 13.1% increased compared to 3.2% same period last year
- Net Debt increased by $144 mln over the past reporting period (81.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 62.0% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -1.3% vs S&P500 -0.4%
2025-11-15
#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for 2025 q3
(2025-08-08, Before Market Open):

- Revenue +29.7% YoY (vs 0.0% in previous quarter and historical rate +7.8%)
- EBITDA margin -4.2% decreased compared to 0.0% same period last year
- Net Debt increased by $24 mln over the past reporting period (90.7% of market cap)
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +3.1% vs S&P500 +0.2%
2025-11-15
#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194103)
(2025-11-03, Before Market Open):

- Revenue +17.9% YoY (vs +16.7% in previous quarter and historical rate +35.7%)
- EBITDA margin 12.1% increased compared to -10.7% same period last year
- Net Debt decreased by $27 mln over the past reporting period (29.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 33.3x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.1% vs S&P500 +0.6%
2025-11-15
#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194100)
(2025-08-12, Before Market Open):

- Revenue +67.3% YoY (vs -18.7% in previous quarter and historical rate +49.9%)
- EBITDA margin -52.2% increased compared to -80.0% same period last year
- Net Debt increased by $658 mln over the past reporting period (16410.8% of market cap)
- FCF (LTM) -$2.1 bln (negative), 51377.2% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -1.4x

2025-11-15
#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194099)
(2025-11-05, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +31.2%)
- Net Debt increased by $1 mln over the past reporting period (9.9% of market cap)
- FCF (LTM) +$0 bln (positive), 69.3% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1.2x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +2.2% vs S&P500 -0.1%
2025-11-15
#reports #UTMD

[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194098)
(2025-05-15, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +3.0%)
- EBITDA +66.7% YoY (vs 0.0% in previous quarter and historical rate -2.0%)
- EBITDA margin 50.0% increased compared to 30.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.3 bln (positive), 151.8% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 12.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +1.7% vs S&P500 -0.4%
2025-11-15
#reports #TPIC

[TPI Composites](https://eninvs.com/all.php?name=TPIC) (Industrial company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194096)
(2025-08-11, After Market Close):

- Revenue -38.6% YoY (vs -11.0% in previous quarter and historical rate -9.8%)
- EBITDA margin -33.3% decreased compared to -1.0% same period last year
- Net Debt decreased by $147 mln over the past reporting period (2432.0% of market cap)
- FCF (LTM) -$0 bln (negative), 165.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -23.3% vs S&P500 +0.3%
2025-11-15
#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194092)
(2025-11-13, After Market Close):

- Revenue +10.5% YoY (vs +25.0% in previous quarter and historical rate +29.5%)
- EBITDA margin -33.3% increased compared to -47.4% same period last year
- Net Debt increased by $43 mln over the past reporting period (94.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 121.3% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -5.4% vs S&P500 -1.1%
2025-11-15
#reports #SMWB

[Similarweb Ltd.](https://eninvs.com/all.php?name=SMWB) (Internet Content and Information) reported for 2025 q3
(2025-11-11, After Market Close):

- Revenue +10.8% YoY (vs +16.4% in previous quarter and historical rate +14.0%)
- EBITDA margin -4.2% decreased compared to -3.1% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -15.1% vs S&P500 +0.3%